Comparison
2q13 Microdeletion Syndrome C6012360 vs 14q24 1q24 3 Microdeletion Syndrome C4750911
Clinical comparison between 2q13 Microdeletion Syndrome and 14q24 1q24 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
2q13 Microdeletion Syndrome C6012360
A rare genetic condition where a small piece of chromosome 2 is missing. It can affect development and cause distinctive features. Care involves multiple specialists based on symptoms.
14q24 1q24 3 Microdeletion Syndrome C4750911
A rare genetic deletion involving part of chromosome 14. It can affect development and lead to various medical issues. Management focuses on supportive care and addressing specific needs.
6 comparison axes
Onset
2q13 Microdeletion Syndrome C6012360
Variable
14q24 1q24 3 Microdeletion Syndrome C4750911
0-null
Onset patterns differ
Severity
2q13 Microdeletion Syndrome C6012360
severe
14q24 1q24 3 Microdeletion Syndrome C4750911
moderate
Different severity levels
Chronic
2q13 Microdeletion Syndrome C6012360
Chronic
14q24 1q24 3 Microdeletion Syndrome C4750911
Chronic
Differing course
Communicable
2q13 Microdeletion Syndrome C6012360
No
14q24 1q24 3 Microdeletion Syndrome C4750911
No
Different transmission
Body System
2q13 Microdeletion Syndrome C6012360
congenital
14q24 1q24 3 Microdeletion Syndrome C4750911
congenital
Same/different system
Category
2q13 Microdeletion Syndrome C6012360
rare-disease
14q24 1q24 3 Microdeletion Syndrome C4750911
genetic
Different category
Bottom line
2q13-microdeletion-syndrome-C6012360 and 14q24-1q24-3-microdeletion-syndrome-C4750911 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2q13 Microdeletion Syndrome C6012360 | 14q24 1q24 3 Microdeletion Syndrome C4750911 | Discriminating power |
|---|---|---|---|
| Developmental concerns | May occur; severity and pattern are not defined by the supplied data. | May occur; individual features are not established here. | Low |
| Recognized onset | Described as variable rather than fixed. | Onset is recorded as 0-null and is not clinically interpretable. | Moderate |
| Overall clinical severity | Labeled severe in the source classification. | Labeled moderate in the source classification. | Moderate |
When to favor each condition
Choose 2q13 Microdeletion Syndrome C6012360 when
A confirmed deletion involves chromosome 2q13.
The chromosomal locus, not symptoms alone, identifies this condition.
High
Source severity is classified as severe.
This matches the supplied severity axis, pending clinical review.
Moderate
Onset is variable across affected people.
Variable onset is the only onset description supplied for the left condition.
Low
Choose 14q24 1q24 3 Microdeletion Syndrome C4750911 when
A confirmed deletion involves 14q24.1–q24.3.
The specified chromosome 14 interval distinguishes it from 2q13.
High
Source severity is classified as moderate.
This matches the supplied severity axis but does not predict an individual course.
Moderate
Supportive care is planned without a defined onset.
The supplied onset field is unusable, so management should follow identified needs.
Low
How key tests differ
| Test | 2q13 Microdeletion Syndrome C6012360 | 14q24 1q24 3 Microdeletion Syndrome C4750911 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May identify a deletion at 2q13. | May identify a deletion at 14q24.1–q24.3. | The locus determines the label; a clinician must interpret size and clinical relevance. |
| Karyotype | May miss a small 2q13 deletion. | May miss a small 14q deletion. | A normal karyotype does not exclude either microdeletion. |
| Symptom-based laboratory panel | No specific abnormality is established here. | No specific abnormality is established here. | Abnormal results are findings, not diagnoses, and require clinician interpretation. |
Prognosis comparison
2q13 Microdeletion Syndrome C6012360
- Outcome
- Long-term outcome is not established; source severity is severe and course chronic.
- Factors
- Deletion confirmation, associated findings, and access to coordinated care.
14q24 1q24 3 Microdeletion Syndrome C4750911
- Outcome
- Long-term outcome is not established; source severity is moderate and course chronic.
- Factors
- Deletion interval, individual medical needs, and supportive services.
Time frame: No reliable time frame is supplied.
Do not infer survival or disability from these labels alone.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental difficulty | Possible; exact manifestations are not supplied. Possible; exact manifestations are not supplied. Neither description establishes a definitive complication profile. |
| Multisystem medical needs | Care may involve multiple specialists. Management emphasizes supportive care for specific needs. Needs should be determined individually rather than assumed from the syndrome name. |
| Long-term course | Classified as chronic and severe. Classified as chronic and moderate. These labels do not establish mortality, disability, or treatment response. |
Patient education highlights
- HighGenetic confirmation
The diagnosis depends on the confirmed chromosomal deletion and clinical interpretation.
- HighIndividual variation
People with the same syndrome label may have different needs; predictions from sparse data are unreliable.
- MediumCare planning
Neither condition is communicable. Care is supportive and coordinated around identified symptoms.